CARNEGIE MELLON UNIVERSITY - Q4 2021 holdings

$250 Million is the total value of CARNEGIE MELLON UNIVERSITY's 6 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was - .

 Value Shares↓ Weighting
IEMG NewISHARES INCcore msci emkt$152,993,0002,555,842
+100.0%
61.20%
NewDUOLINGO INC$93,271,000879,000
+100.0%
37.31%
NBSE NewNEUBASE THERAPEUTICS INC$2,640,000939,412
+100.0%
1.06%
VERA NewVERA THERAPEUTICS INC$858,00032,120
+100.0%
0.34%
NewPREDICTIVE ONCOLOGY INC$197,000207,144
+100.0%
0.08%
IHT NewINNSUITES HOSPITALITY TRsh ben int$22,00010,000
+100.0%
0.01%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-02-11
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ISHARES INC8Q3 202379.8%
DUOLINGO INC8Q3 202377.3%
NEUBASE THERAPEUTICS INC.8Q3 20231.1%
VERA THERAPEUTICS INC.8Q3 20230.4%
PREDICTIVE ONCOLOGY INC.8Q3 20230.1%
INNSUITES HOSPITALITY TRUST8Q3 20230.0%
CARMELL THERAPEUTICS CORP1Q3 20230.5%

View CARNEGIE MELLON UNIVERSITY's complete holdings history.

Latest significant ownerships (13-D/G)
CARNEGIE MELLON UNIVERSITY Q4 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
NeuBase Therapeutics, Inc.July 22, 2019939,4125.5%

View CARNEGIE MELLON UNIVERSITY's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-02
13F-HR2023-11-01
13F-HR2023-08-01
13F-HR2023-05-03
13F-HR2023-02-07
13F-HR2022-11-10
13F-HR2022-08-05
13F-HR2022-05-10
13F-HR2022-02-11
SC 13G2019-07-22

View CARNEGIE MELLON UNIVERSITY's complete filings history.

Compare quarters

Export CARNEGIE MELLON UNIVERSITY's holdings